Tomoko Hasunuma

2.9k total citations
89 papers, 2.3k citations indexed

About

Tomoko Hasunuma is a scholar working on Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tomoko Hasunuma has authored 89 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 21 papers in Molecular Biology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tomoko Hasunuma's work include T-cell and Retrovirus Studies (25 papers), Animal Disease Management and Epidemiology (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Tomoko Hasunuma is often cited by papers focused on T-cell and Retrovirus Studies (25 papers), Animal Disease Management and Epidemiology (17 papers) and Rheumatoid Arthritis Research and Therapies (17 papers). Tomoko Hasunuma collaborates with scholars based in Japan, United States and United Kingdom. Tomoko Hasunuma's co-authors include Hiroyuki Aono, Takayuki Sumida, Tetsuji Kobata, Kusuki Nishioka, K Nishioka, Hiroshi Asahara, Kusuki Nishioka, Kazuyoshi Okamoto, T Kobata and Koushi Fujisawa and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

In The Last Decade

Tomoko Hasunuma

83 papers receiving 2.2k citations

Peers

Countries citing papers authored by Tomoko Hasunuma

Since Specialization

Citations

This map shows the geographic impact of Tomoko Hasunuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Hasunuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Hasunuma more than expected).

Fields of papers citing papers by Tomoko Hasunuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Hasunuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Hasunuma. The network helps show where Tomoko Hasunuma may publish in the future.

Co-authorship network of co-authors of Tomoko Hasunuma

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Hasunuma. A scholar is included among the top collaborators of Tomoko Hasunuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Hasunuma. Tomoko Hasunuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Food, Gastric Acid Reduction, and Strong CYP3A Induction on the Pharmacokinetics of Tasurgratinib, a Novel Selective Fibroblast Growth Factor Receptor Inhibitor 2024 ·The Journal of Clinical Pharmacology ·(unknown), Tomoko Hasunuma, (unknown), (unknown), (unknown), Setsuo Funasaka, (unknown), Kenya Nakai, Sanae Yasuda	1
2	Overall Similarities and a Possible Factor Affecting Plasma Metabolome Profiles Between Venous and Capillary Blood Samples From 20 Healthy Human Males 2019 ·Journal of Pharmaceutical Sciences ·Kosuke Saito, Satoko Ueno, Akira Nakayama, (unknown), Koji Y. Arai, Tomoko Hasunuma, Yoshiro Saito	5
3	A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy 2014 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·(unknown), Tomoko Hasunuma, Kenji Takagi, (unknown), (unknown), (unknown), Sei Muraoka, Kanako Kitahara, (unknown), Kaichi Kaneko, (unknown), Hirahito Endo, Shinichi Kawai	4
4	The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine 2011 ·European Journal of Clinical Pharmacology ·Junichi Azuma, Tomoko Hasunuma, Masanori KUBO, (unknown), (unknown), (unknown), Tsutomu Fujiwara, (unknown), (unknown), (unknown)	37
5	A randomized, double-blind, placebo-controlled, single-dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of denosumab administered subcutaneously to postmenopausal Japanese women 2011 ·Bone ·Yuji Kumagai, Tomoko Hasunuma, Desmond Padhi	26
6	Effect of Renal Impairment on the Pharmacokinetics of Disopyramide and Its Metabolite and Serum Insulin Level: A Single Dose Study 2009 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Kazuhiro Harada, Tomoko Hasunuma, Tsutomu Kotegawa, Eiji Uchida, Tomonori Tateishi, Takehiko Kawanishi, (unknown)	1
7	Effects of Colforsin Daropate Hydrochloride (Adehl Inj.), Anti-Acute Heart Failure Agent, on Adenylate Cyclase-Related Hormone Actions 2004 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·(unknown), Saichi Hosoda, Yoshihiro Ishikawa, (unknown), Tomoko Hasunuma, Masahiko Nakamura, Kuniaki Iwasawa, Hiroshi Yamashita, Hiroyuki Matsuda, Tetsuya Kurosu, Kazuo UEBABA, Kanki Komiyama	0
8	Potential role ofHOXD9 in synoviocyte proliferation 2001 ·Arthritis & Rheumatism ·Khoa Nguyen, Minako Nakazawa, Tomoko Hasunuma, Toshihiro Nakajima, Hiroshi Nakamura, Tetsuji Kobata, Kusuki Nishioka	9
9	Infection of synoviocytes with HTLV-I induces telomerase activity 2001 ·Rheumatology International ·(unknown), T Kobata, (unknown), Atsuko Uchida, (unknown), (unknown), Tomoko Hasunuma	8
10	Synovial hyperplasia in HTLV-I associated arthropathy is induced by tumor necrosis factor-alpha produced by HTLV-I infected CD68+ cells. 2000 ·PubMed ·Weihong Yin, Tomoko Hasunuma, T Kobata, Takayuki Sumida, K. Nishioka	11
11	CBP: A Target Molecule of HTLV-1 Tax in Synoviocyte Activation 2000 ·Biochemical and Biophysical Research Communications ·Minako Nakazawa, Tomoko Hasunuma, Takayuki Ohshima, Yuetsu Tanaka, Kusuki Nishioka, Toshihiro Nakajima	4
12	Expression of murineHOXD9 during embryonic joint patterning and in human T lymphotropic virus type Itax transgenic mice with arthropathy resembling rheumatoid arthritis 1999 ·Arthritis & Rheumatism ·Khoa Nguyen, Tomoko Hasunuma, Tetsuji Kobata, Tomohiro Kato, Kusuki Nishioka	9
13	Direct evidence of high DNA binding activity of transcription factor AP‐1 in rheumatoid arthritis synovium 1997 ·Arthritis & Rheumatism ·Hiroshi Asahara, (unknown), Tetsuji Kobata, Tomoko Hasunuma, Toshiro Maeda, Masato Asanuma, Norio Ogawa, Hajime Inoue, (unknown), Kusuki Nishioka	94
14	Selective activation of the JNK/AP‐1 pathway in FAS‐mediated apoptosis of rheumatoid arthritis synoviocytes 1997 ·Arthritis & Rheumatism ·Kazuyoshi Okamoto, Koushi Fujisawa, Tomoko Hasunuma, Tetsuji Kobata, Takayuki Sumida, Kusuki Nishioka	33
15	Oligoclonal Proliferation of Human T-Cell Leukemia Virus Type I Infected Lymphocytes in Lesions of Virus-Induced Arthropathy 1995 ·Biochemical and Biophysical Research Communications ·Kazuhiko Yamamoto, Hiroyuki Aono, Takeshi Nakajima, Tomoko Hasunuma, K Nishioka	10
16	Establishment and Characterization of Synovial Cell Clones with Integrated Human T-Cell Leukemia Virus Type-I 1994 ·Clinical Immunology and Immunopathology ·Tomoko Hasunuma, Toshihiro Nakajima, Hiroyuki Aono, Kazuto Sato, Tsukasa Matsubara, Kazuhiko Yamamoto, Kusuki Nishioka	16
17	Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys 1992 ·The Journal of Immunology ·(unknown), D J Ringler, Michael D. Miller, Yasuhiro Yasutomi, Tomoko Hasunuma, Norman L. Letvin	23
18	Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes 1992 ·The Journal of Immunology ·Tomoko Hasunuma, Hiroshi Tsubota, Mamoru Watanabe, Z W Chen, Carol I. Lord, Linda C. Burkly, J F Daley, Norman L. Letvin	18
19	Bucillamine nephropathy. 1991 ·Ensho ·Ayako Nakajima, Tomoko Hasunuma, Takashi Yamada, Makoto Goto, Kusuki Nishioka	0
20	Selective Inhibition of Cytotoxic T Lymphocyte Proliferation by Mizoribine (Bredinin), an Adenosine Analog 1989 ·Advances in experimental medicine and biology ·Tomoko Hasunuma, Hisashi Yamanaka, Chihiro Terai, Nobuyuki Miyasaka, Naoyuki Kamatani, Kusuki Nishioka, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact